Lexington Pharmaceutical Company Developing COVID-19 Spray

A Lexington pharmaceutical company is working to produce a nasal spray that could prevent one from catching COVID-19, as well as keep symptoms at bay in patients who have already tested positive for the highly contagious virus.Summit Biosciences, Inc. announced this week it had been awarded a contract from a Seattle-based pharmaceutical company, Atossa Therapeutics, Inc., to fast track the development of a nasal spray to be used on patients who’ve been diagnosed with the novel coronavirus but who “have not yet exhibited symptoms severe enough to require hospitalization,” according to the press release.




Source: MG News


Return to News